MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Depreciation in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q3 2024.
  • Maravai Lifesciences Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $5.04M, a 23.9% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. Depreciation for the twelve months ending September 30, 2024 was $19.3M, a 76.8% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Depreciation for 2023 was $12.9M, a 70.5% increase from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Depreciation for 2022 was $7.57M, a 18% increase from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Depreciation for 2021 was $6.41M, a 14.7% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $19.3M $5.04M +$973K +23.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $18.3M $5.56M +$2.74M +97.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $15.6M $4.79M +$2.71M +130% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.9M $3.93M +$1.97M +100% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $10.9M $4.07M +$2.21M +119% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $8.71M $2.82M +$923K +48.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $7.79M $2.08M +$225K +12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $7.57M $1.96M +$217K +12.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $7.35M $1.86M +$60K +3.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $7.29M $1.89M +$277K +17.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $7.01M $1.86M +$599K +47.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $6.41M $1.75M +$908K +108% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $5.51M $1.8M +$166K +10.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $5.34M $1.62M +$181K +12.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $5.16M $1.26M -$435K -25.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $5.59M $837K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $1.63M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.43M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.69M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.